LONDON (Reuters) - Stamping out trade in counterfeit drugs like Roche's Avastin is an uphill fight for regulators, whose task is complicated by the presence of thousands of small wholesalers across Europe. In Britain alone - the transit point for a second fake batch of the cancer drug uncovered in the U.S. market - there are around 1,800 licensed wholesalers, according to the Medicines and Healthcare products Regulatory Agency (MHRA). ...
Courtesy of Yahoo News
No comments:
Post a Comment